Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026)

Bausch Health Companies (BHC) reported Shares Outstanding (Entity) of $373.5 million for Q1 2026, up 1.06% on a YoY basis from $369.5 million in Q1 2025, and up 0.79% sequentially from $370.5 million in Q4 2025.

Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Shares Outstanding (Entity) data on file, last reported at $373.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 1.06% year-over-year to $373.5 million; the trailing twelve-month figure through Mar 2026 stood at $373.5 million (up 1.06% YoY), and the FY2025 full-year result was $370.5 million, up 0.73% from the prior year.
  • Shares Outstanding (Entity) rose to $373.5 million in Q1 2026, from $370.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $373.5 million in Q1 2026 to a low of $361.3 million in Q1 2022.
  • A 5-year average of $366.3 million and a median of $366.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) climbed 0.63% in 2023 and advanced 1.06% in 2026, its largest moves.
  • Tracing BHC's Shares Outstanding (Entity) over 5 years: stood at $361.9 million in 2022, then grew by 0.92% to $365.2 million in 2023, then climbed by 0.71% to $367.8 million in 2024, then gained by 0.73% to $370.5 million in 2025, then rose by 0.79% to $373.5 million in 2026.
  • Business Quant data shows BHC's Shares Outstanding (Entity) at $373.5 million in Q1 2026, $370.5 million in Q4 2025, and $370.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 43.50 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 31.59 Bn
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 497.70 Mn
10 Bausch Health Companies 1.65 Bn 333.91 Mn 2.52 Bn 372.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 372.80 Mn
Dec 31, 2025 370.90 Mn
Sep 30, 2025 371.30 Mn
Jun 30, 2025 370.90 Mn
Mar 31, 2025 369.60 Mn
Dec 31, 2024 368.00 Mn
Sep 30, 2024 368.40 Mn
Jun 30, 2024 367.90 Mn
Mar 31, 2024 366.80 Mn
Dec 31, 2023 364.90 Mn
Sep 30, 2023 365.40 Mn
Jun 30, 2023 364.80 Mn
Mar 31, 2023 363.30 Mn
Dec 31, 2022 362.00 Mn
Sep 30, 2022 362.50 Mn
Jun 30, 2022 362.20 Mn
Mar 31, 2022 360.80 Mn
Dec 31, 2021 358.90 Mn
Sep 30, 2021 359.60 Mn
Jun 30, 2021 359.10 Mn